Genmab — Maj 2023
-
Biontech conf call https://www.fool.com/earnings/call-transcripts/2023/05/08/biontech-se-bntx-q1-2023-earnings-call-transcript/ "in principle, FixVac could be an option for patients with advanced metastatic disease. But again, here, it's a question of the combination compounds. And this is something that is now in the focus of our upcoming studies evaluating the use of these vaccines in combination with our checkpoint immunomodulators, for example, the bispecific BNT312 and BNT311 molecules,
" -
https://labuonasalute.it/2023/05/08/tumori-del-sangue-3.html teclistamab in Italie now
-
Ofte ser man biotech aktier stige frem mod mulig godkendelse. Genmab går i den anden retning. Nogen der ved om der er analytikere der hælder til et nej i denne omgang?
-
small new trial: Daratumumab in Acquired Hemophilia A https://clinicaltrials.gov/ct2/show/NCT05849740
-
and another one: Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma https://clinicaltrials.gov/ct2/show/NCT05849610
-
Spotlight On: Chris Cozic, Executive Vice President & Chief People Officer, Genmab https://www.capitalanalyticsassociates.com/spotlight-on-chris-cozic-executive-vice-president-chief-people-officer-genmab/
-
Godmorgen
-
Her medd. og indbydelse til CC https://ir.genmab.com/events-and-presentations#content
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind